Abstract 1482P
Background
More than 80% patients of Carcinoma Gall bladder (Ca GB) present with unresectable or disseminated disease. In these patients jaundice can be very distressing leading to poor quality of life (QOL) PTBD has been advocated to palliate this but, its impact on QOL has not been adequately studied.
Methods
Prospective observational study over two years included patients of proven unresectable/disseminated Ca GB presenting with jaundice. Pre-procedure parameters were recorded and PTBD done. Quality of Life (QOL) was assessed by EORTC QLQ-C30 and BIL-21 scores prior to the treatment and after 1- month. Post procedure complications were reported. Follow up was done at 1,3 and 6 months.
Results
Study included 43 patients of unresectable/disseminated Ca GB. Median age was 52 years with 74% females. 26 patients underwent unilateral (U/L) and 17 bilateral (B/L) PTBD. 4 patients needed B/L PTBD for inadequate bilirubin fall at 4 weeks. Mean serum bilirubin was 18.3 ± 7.3 mg/dl, albumin was 2.9 ± 0.5 mg/dl and INR was 1.7 ± 1.2. Commonest indication for PTBD was pruritus (65%) and only 12% patients had cholangitis. Bilirubin level at 1 week and 1 month was 15mg/dl and 7.1 mg/dl respectively(p=0.0002). Unfortunately, EORTC QLQ-C30 QOL scores showed decline in all aspects at 1 months and 3 months. Even in BIL-21 scores although there was improvement in Jaundice scale those with anxiety, pain and side effects had decline. Most patients had morbidity related to either slippage of PTBD or peri-tubal leakage. Also, inevitability of disease progression due to lack of treatment caused significant anxiety. 4 patients expired within 30 days due to cholangitis. Survival at 1-, 3- and 6- months was 60%, 23% and 7% respectively with median survival of 38 days.
Conclusions
Although jaundice is a fairly debilitating symptom in patients with unresectable Ca GB, palliation in form of PTBD may not always lead to improvement of QOL. Psychological counselling and proper guidance in terms of care of drains as well proper pain management is imperative to provide these terminally ill patients with best supportive care.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
S. Galodha.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1492P - The role of LACE index in predicting 30-day unplanned readmission in patients receiving immunotherapy
Presenter: Duygu Ercan Uzundal
Session: Poster session 10
1493P - The Italian version of the FAMCARE-P13 questionnaire: A validation study
Presenter: Giacomo Massa
Session: Poster session 10
1494P - Prognostic features in NSCLC patients with ECOG-PS 2-4: A prospective cohort study
Presenter: Gilberto De Castro Jr.
Session: Poster session 10
1495P - Impact of social isolation on the clinical outcomes in advanced NSCLC patients
Presenter: Yoh Yamaguchi
Session: Poster session 10
1496P - Predictors of early mortality after hemodialysis in patients with cancer and acute kidney injury
Presenter: Suleyman Cagin Gurbuz
Session: Poster session 10
1497P - Resuscitation decisions in advanced cancer: A mixed methods study exploring survival outcomes and views of healthcare professionals
Presenter: Rachel Prichard
Session: Poster session 10
1498P - Acute myeloid leukemia: Trends in palliative care utilization in hospitalized patients over 65 years old - A national inpatient sample study (2016-2020)
Presenter: Marco Bermudez
Session: Poster session 10
Resources:
Abstract
1499P - Knowledge, attitudes, and current practices toward lung cancer palliative care management in China: A national survey
Presenter: Mengting Chen
Session: Poster session 10
Resources:
Abstract
1500P - Caring for carers: The impact of death & dying on doctors-in-training in an Irish tertiary referral hospital
Presenter: Conor Moloney
Session: Poster session 10
1501P - Sex-specific variation in symptoms presentation: Experience of an outpatient clinic integrated model between radiotherapy and palliative care
Presenter: Luca Tontini
Session: Poster session 10